EW (Edwards Lifesciences Corp) Technical Analysis

EW Technical Analysis leverages historical price and volume data to provide real-time indicator values and signals, including RSI, MACD, Bollinger Bands, and volume, to reflect market momentum, volatility ranges, and price-volume dynamics. It also integrates market sentiment metrics such as the VIX volatility index, Advance-Decline ratio (A/D ratio), and Put/Call options ratio for broader market context. Multi-timeframe views span from minute intervals to daily, weekly, and monthly charts, making it easy to track indicator behavior across periods. Key support and resistance levels are displayed alongside current prices, calculated via pivots, Fibonacci retracements, and historical extremes to offer an immediate overview of market structure.
EW
EW

Edwards Lifesciences Corp

$91.11+0.86%
Today's High$91.76
Today's Low$90.05
Today's Open$90.22
Yesterday's Close$90.33

EW (Edwards Lifesciences Corp) Technical Analysis Overview

AI CreationAs of June 30, 2026, Edwards Lifesciences Corp (EW) is showing mixed technical signals with a bullish moving average structure offset by weak trend confirmation. The MACD Level at 1.56 carries a Buy signal, while the RSI(14) reading of 60.73 sits in the strong zone (55–70 range), indicating sustained buying pressure. The moving average system displays strong bullish alignment, with EMA10 at 89.01, EMA20 at 87.75, EMA50 at 85.56, and SMA200 at 82.29 all stacked in bullish order, confirming intermediate-term upside bias. The ADX(14) value of 17.39 signals weak trend strength, implying the current structure is vulnerable to consolidation rather than sustained directional movement, creating a divergence between price structure and momentum confirmation that characterizes the **EW technical analysis** outlook.

Oscillators

Strong Sell
Strong Buy
Sell
3
Sell
7
Neutral
1
Buy

Summary

Strong Sell
Strong Buy
Buy
4
Sell
8
Neutral
14
Buy

Moving Averages

Strong Sell
Strong Buy
Strong Buy
1
Sell
1
Neutral
13
Buy

EW (Edwards Lifesciences Corp) Live Candlestick Chart

EW (Edwards Lifesciences Corp) Multi-Timeframe Technical Rating

Summary1H4H1D1W
Moving Averages (15)131140131140
Oscillators (11)NeutralNeutralNeutralNeutral
RSI (14)55.961.763.363.1
MACD (12,26)Golden CrossGolden CrossGolden CrossGolden Cross

EW (Edwards Lifesciences Corp) Technical Indicator Interpretation

Based on 1-day closing price series

Oscillators

NameValueOperation
RSI(14)
63.3139Neutral
Stochastic %K (14, 3, 3)
79.8146Neutral
Commodity Channel Index (CCI) (20)
122.8396Sell
Average Directional Index (ADX) (14)
17.5244Neutral
Awesome Oscillator (AO)
4.7423Neutral
Momentum Indicator (10)
2.54Sell
MACD Level (12, 26)
1.6468Buy
Stochastic RSI Fast (3, 3, 14, 14)
89.5609Sell
Williams Percent Range (%R) (14)
-18.1256Neutral
Bull Bear Power (BBP)
4.2097Neutral
Ultimate Oscillator (UO) (7, 14, 28)
46.5741Neutral

Moving Averages

NameValueOperation
EMA (10)
89.4317Buy
SMA (10)
88.979Buy
EMA (20)
88.0909Buy
SMA (20)
87.715Buy
EMA (30)
87.1072Buy
SMA (30)
87.0237Buy
EMA (50)
85.785Buy
SMA (50)
84.9164Buy
EMA (100)
84.2004Buy
SMA (100)
83.134Buy
EMA (200)
82.4157Buy
SMA (200)
82.3551Buy
Ichimoku Kinko Hyo Base Line (9, 26, 52, 26)
88.025Neutral
Volume-Weighted Moving Average (VWMA) (20)
87.8517Buy
Hull Moving Average (HMA) (9)
91.7646Sell

EW (Edwards Lifesciences Corp) Pivot Points

Based on 1-day timeframe

PriceClassicFibonacciCamarillaWoodieDM
R3108.256798.546793.1302105.575-
R298.546794.837492.240299.2275-
R194.503392.545991.350195.86596.525
Pivot P88.836788.836788.836789.517589.8475
S184.793385.127489.569986.15586.815
S279.126782.835988.679879.8075-
S369.416779.126787.789876.445-

EW (Edwards Lifesciences Corp) Market Sentiment Index

Analyst Rating96.9231
Options Put/Call Ratio+48.62%
Implied Volatility (IV)47.9791

EW (Edwards Lifesciences Corp) Deep Technical Analysis

As of June 30, 2026, Edwards Lifesciences Corp (EW) is exhibiting a mixed technical structure with bullish moving average support but moderate momentum confirmation. The MACD Level at 1.56 carries a Buy signal, suggesting that upside momentum remains intact across the daily timeframe, though the broader momentum picture requires validation from other indicators. The RSI(14) at 60.73 occupies the strong zone (55–70 range), indicating sustained buying interest with bullish forces maintaining slight dominance, confirming modest support to the bullish case for **EW price outlook**. The ADX(14) reading of 17.39 carries a Neutral signal and indicates weak trend strength, suggesting the market structure is more prone to range-bound or oscillating behavior rather than strong directional persistence. The Commodity Channel Index (20) at 129.10 shows a Sell signal, indicating overbought conditions and potential mean reversion risk, while the Momentum(10) at 3.95 with a Sell signal diverges from the MACD's bullish stance. Together, these indicators imply that while the moving average system shows directional intent, the underlying trend strength is insufficient to sustain a decisive advance without additional confirmation from price action. The moving average system demonstrates consistent bullish alignment across multiple timeframes. The EMA10 at 89.01 sits marginally above the EMA20 at 87.75, with both positioned above the EMA50 at 85.56 and SMA200 at 82.29, forming a stacked bullish arrangement that supports near-term upside bias. The EMA20 and EMA50 serve as intermediate support levels, while the SMA200 at 82.29 anchors the longer-term bullish structure, and the **EW market analysis** reveals that any pullback would likely find initial support near the EMA50, with the SMA200 providing medium-term structural support. In terms of key levels, the Fibonacci retracement structure offers several reference points for trading decisions. Resistance targets are positioned at R1 (88.25), R2 (91.03), and R3 (95.54), while support levels are anchored at S1 (79.24), S2 (76.46), and S3 (71.96). The current price of 90.11 sits near the EMA20 and SMA20, suggesting the asset remains in consolidation territory with the recent high of 91.00 approaching the R1 Fibonacci level. The intraday range from 89.56 to 91.00 reflects measured volatility consistent with the weak ADX reading, suggesting traders remain cautious about pushing prices decisively higher. On the market breadth front, Edwards Lifesciences Corp displays mixed sentiment dynamics. The analyst rating stands at 96.92, reflecting overwhelmingly positive fundamental and technical sentiment among professional observers, while the implied volatility at 45.19 suggests moderately elevated option premium pricing. The put/call ratio of 130.55 indicates elevated hedging demand and a bias toward defensive positioning despite bullish analyst consensus, reinforcing the technical picture of consolidation and supporting the near-term **EW price prediction** of range-bound behavior before any decisive directional breakout.

FAQ

What is the current technical rating for EW?

x
On the 4H timeframe, the aggregate technical rating for EW is Buy. This rating is dynamically aggregated from moving averages and momentum oscillators to reflect the prevailing trend direction and price velocity.

Where are the key support and resistance levels for EW?

x

What are the current RSI and MACD signals for EW?

x

How often is the EW technical analysis data updated?

x

Continue Exploring EW (Edwards Lifesciences Corp)

Risk Warning:

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Warning.

Disclaimer:

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.